1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Evidence for AI in Health Initiative for Evaluating AI Clinical Decision Support in Low and Middle Income Countries (EVAH) is sponsored by Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust. A joint investment to support rigorous, country-led evaluations of AI health tools in low- and middle-income countries (LMICs).
Get alerted about grants like this
Get emailed when new opportunities from “Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Evidence for AI in Health (EVAH) RFP | The Abdul Latif Jameel Poverty Action Lab Evidence for AI in Health (EVAH) RFP The Evidence for AI in Health (EVAH) initiative is supported by the Wellcome Trust , Gates Foundation , and Novo Nordisk Foundation , and delivered in partnership with the Abdul Latif Jameel Poverty Action Lab (J-PAL) and the African Population and Health Research Center (APHRC).
EVAH’s first request for proposals (RFP) supports locally-led evaluations of AI-enabled clinical decision support tools (CDSTs) that are ready for real-world use and designed to assist frontline workers with clinical tasks—such as triage, diagnosis, or referral—within primary and community health care settings in Sub-Saharan Africa, South Asia, and Southeast Asia.
The Evidence for AI in Health (EVAH) initiative Spring 2026 RFP is now closed. Below are the key dates: RFP opens: February 20, 2026 RFP questions accepted: Questions must have been submitted to [email protected] by March 6, 2026 to be published and answered in the FAQ below. Due to the volume of questions and to ensure applicants have equal access to information, we are unable to respond individually to every inquiry.
Proposals due: (CLOSED) April 1, 2026 at 10:00am EDT / 4:00pm Central Africa Time / 7:30pm Indian Standard Time Anticipated notification date: June 2026 -- UPDATE : We apologize for the delay. We are actively working on sending decision emails to all on-time EVAH applicants. We now expect all decision emails will go out by mid-July.
Late applications were not considered further and will not receive a decision email. Note: This is when we estimate that applicants will first be notified whether their proposal is advancing with a funder (either Wellcome Trust, Gates Foundation, or Novo Nordisk Foundation) for further due diligence. Final funding decisions and associated timeline to award remain subject to each funder’s internal due diligence processes.
Researchers may apply for one of the following funding pathways: Pathway A: supports real-world evaluation of AI-enabled CDSTs that are early in deployment. The pathway focuses on how the tools perform in practice, including usability, workflow integration, adoption, and safety, and supports research that can inform future impact evaluations.
(Up to USD $1,000,000) Pathway B : supports rigorous impact evaluations of AI-enabled CDSTs that are ready to be deployed at scale. This pathway focuses on measuring the effects of these tools on health outcomes and system performance at scale.
(Up to USD $3,000,000) This call is intended for organizations or consortia that have access to an AI-enabled CDST already deployed or ready for deployment in primary health care settings, and the capacity to conduct—or partner with institutions that can conduct—rigorous evaluations.
Applicants may include nonprofit organizations, for-profit companies, international organizations, government agencies, academic institutions, or collaborations among these actors.
Proposals should be led by institutions based in the regions of focus and designed to generate decision-relevant evidence for Ministries of Health, implementers, and funders on how AI-enabled CDSTs can be responsibly integrated into primary health care systems and, where appropriate, inform future scale-up decisions. Please refer to the RFP overview for additional details on eligibility and priorities.
For EVAH RFPs, please follow the directions listed below: When you are ready to apply, please refer to these instructions to create your team’s profile on Wizehive, our application portal. Please note that we are adapting WizeHive’s “Organization Profile” feature to serve as a “Proposal Team Profile. ” As such, each team profile corresponds to a single proposal.
Teams will now be able to collaborate on their proposal in WizeHive. Submit your proposal by April 1, 2026 at 10:00am Eastern Daylight Time (4:00pm Central Africa Time; 7:30pm Indian Standard Time). Please see the application guidelines at the bottom of this page for a preview of application questions and required materials.
The application guidelines include a checklist of required materials and guidance on what to address within each narrative prompt of the application. We recommend reading the Application Guidelines document in detail before answering the proposal questions in WizeHive . Questions on RFP priorities, application and review processes, eligibility, and general inquiries were collected through [email protected] until March 6 .
Questions and responses are anonymized and published below under Frequently Asked Questions . Due to the volume of questions and to ensure applicants have equal access to information, we are unable to respond individually to every inquiry. Technical support for WizeHive, the application platform, will be provided throughout the RFP process.
Please see the RFP Overview below for more information. Below, please find (1) an RFP Overview; (2) Application Guidelines, which includes a preview of the application questions you will complete on the WizeHive portal; and (3) budget template. Please use the budget template to structure your proposal budget.
All application materials should be completed in or uploaded to our online portal, WizeHive —only applications submitted there can be considered. Request for Proposals Overview EVAH Application Guidelines Frequently Asked Questions WizeHive Application Instructions WizeHive Application Instructions
According to the current listing, eligibility includes: Organizations in low- and middle-income countries (LMICs) proposing evaluations of AI health tools. Confirm the full requirements in the official notice before applying.
The current listing shows $60,000,000 (total investment by all funders). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Evidence for AI in Health Initiative for Evaluating AI Clinical Decision Support in Low and Middle Income Countries (EVAH) is funded by Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
MacKenzie Scott's Yield Giving has moved more than $26 billion — including roughly $7 billion in 2025, over a third of all U.S. megagifts — through unrestricted, trust-based grants with no application. Melinda French Gates's Pivotal Ventures has committed $2 billion to women's health and economic power. The Bezos philanthropies have moved billions more. As the Buffett–Gates era winds down, this new class of megadonor is rewriting the rules of major giving. Here is what changes for nonprofits, and how to become the kind of organization this money finds.
Read articleGates committed $540.2 million over a decade to the Institute for Health Metrics and Evaluation — the largest gift in University of Washington history — while IHME's federal grant income falls from $7.3 million to a projected $4.8 million. The gift is a case study in the anchor-funder model: what it can do that federal money cannot, and the concentration risk it quietly underwrites.
Read articleOn July 14, 2026, Warren Buffett routed his roughly $6 billion annual Berkshire gift to four family foundations and excluded the Gates Foundation — the first exclusion since 2006, pending a review of the foundation's historical ties to Jeffrey Epstein. Buffett has given the Gates Foundation more than $43 billion over two decades. Here is why the pause matters for the world's largest grantmaker, what it reveals about concentration risk in modern philanthropy, and what nonprofits that depend on a single major funder should do now.
Read article